Business Weekly
Business Daily
BBC
4.4 • 816 Ratings
🗓️ 2 January 2021
⏱️ 49 minutes
🧾️ Download transcript
Summary
The UK has given the green light to the Oxford AstraZeneca Covid19 vaccine. It’s cheaper and easier to store than some of the alternatives - and the hope is that will make it easier to distribute globally. However, there are worries that production capacity and an unwillingness to share intellectual data might mean the poorest in the world won’t get the immunisation. We speak to Anna Marriott of Oxfam. Also on the show we’ll be mulling over the Brexit deal. We get the view from businesses both sides of the Channel about what the future will bring now the UK and EU have a new trade relationship. We also hear from former EU trade commissioner Cecilia Malmstrom who tells us what effect the divorce will have on the rest of the union. As the rest of the world continues to struggle with Covid 19, China is getting back to normal. We hear from Wuhan and Shanghai. Plus, food businesses discuss how they’ve adapted to survive during the pandemic. Business Weekly is presented by Lucy Burton and produced by Clare Williamson. (Image:University of Oxford researcher in a laboratory at the Jenner Institute, working on the coronavirus vaccine. Image credit: John Cairns/University of Oxford/PA Wire)
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hello and welcome to the first business weekly of 2021. I'm Lucy Burton. |
| 0:09.9 | And we can kick off the year with some good news. |
| 0:13.1 | Twelve months after the first cluster of a pneumonia-like illness was spotted in China, |
| 0:18.0 | a cheap and easy-to-store COVID vaccine made by Oxford University and |
| 0:22.1 | AstraZeneca has been approved for use in the UK. So we'll be looking at whether this could be |
| 0:27.0 | a game changer for the developing world. We're also going to be talking about the Brexit deal, |
| 0:32.4 | because after decades of debate about the UK's relationship with the EU, one highly divisive vote, |
| 0:38.7 | years of arguing over transition deals, backstops and borders, |
| 0:42.2 | and then final days of high intensity talks about fishing, there is a deal. |
| 0:47.1 | Also on the show, what does the future of food and restaurants look like during and after a pandemic? |
| 0:53.2 | We'll hear from food companies who are having |
| 0:54.9 | to innovate to adapt to a new normal. First though, this week the British Health Secretary said |
| 1:00.5 | we can finally see a way out of the pandemic as regulatory bodies gave the green light to the |
| 1:05.5 | AstraZeneca COVID vaccine designed and made by a team of scientists at Oxford University. |
| 1:10.8 | Here's Andrew Pollard, the head of the of scientists at Oxford University. |
| 1:13.5 | Here's Andrew Pollard, the head of the vaccine group at Oxford. |
| 1:18.4 | This really is a great moment in what's been a difficult year, |
| 1:21.8 | and definitely a moment here in Oxford at the University, |
| 1:26.5 | of pride in our team for this astonishing achievement in science and clinical research during the course of the year. |
| 1:29.7 | I mean, this year with the pandemic has been like being in a blizzard. |
| 1:34.2 | We've been really struggling uphill through snow drifts and with this icy wind in our faces. |
| 1:40.7 | And I think we do have some respite with this good news and the warmth that that brings and perhaps some hope for the future. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from BBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of BBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.